Egecioglu, E. Hedonic and incentive signals for body weight control. /Egecioglu, E., Skibicka, K.P., Hansson, C., Alvarez-Crespo, M., Friberg, A., Jerlhag, E., Engel, J.A., Dickson, S.L. // Reviews in Endocrine and Metabolic Disorders, in press (Epub ahead of print). doi:10.1007/s11154-011-9166-4.

Elias, C. F. Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamus area. /C. F. Elias, C. D Saper, E. Maratos-Flier et al. // J. Comp. Neurol. – 1998. – Vol.402. – P.442–459

Ericson, M. The smoking cessation medication varenicline attenuates alcohol and nicotine interactions in the rat mesolimbic dopamine system. /Ericson, M., Löf, E., Stomberg, R., Soderpalm, B. // Journal of Pharmacology and Experimental Therapeutics329 (1) – 2009 – Р.225–230.

Fadel J. Anatomical substrates of orexin-dopamine interactions: lateral hypothalamic projections to the ventral tegmental area. /Fadel J., Deutch A.Y. // Neuroscience. 2002; 111:379–87. []

Faulconbridge, L.F. Hyperphagic effects of brainstem ghrelin administration. /Faulconbridge, L.F., Cummings, D.E., Kaplan, J.M., Grill, H.J. //Diabetes 52 (9), 2260–2265. Grigson, P.S., 2002. Like drugs for chocolate: separate rewards modulated by common mechanisms? Physiology & Behavior 76 (3) – 2003 – Р.345–346.

Funk C.K. Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanoldependent rats. /Funk C.K., O’Dell L.E., Crawford E.F., Koob G.F. // J Neurosci 2006;26:11324–11332.

Gallistel C.R. Measuring the subjective magnitude of brain stimulation reward by titration with rate of reward. /Gallistel C.R., Leon M. // Behav. Neurosci. 1991. V.105. №6. P.913–925.

Gastard M. The caudal sublenticular region/anterior amygdaloid area is the only part of the rat forebrain and mesopontine tegmentum occupied by magnocelluar cholinergic neurons that receives outputs from the central division of extended amygdala /Gastard M., Jensen S.L., Martin J.R., Williams E.A., Zahm D.S. // Brain Res. 2002. V.957. P.207–222.

George O. CRF-CRF1 system activation mediates withdrawal-induced increases in nicotine selfadministration in nicotine-dependent rats. /George O, Ghozland S, Azar MR, Cottone P, Zorrilla EP, Parsons LH, O’Dell LE, Richardson HN, Koob GF. // Proc Natl Acad Sci USA 2007;104:17198–17203.

Goeders N.E. The impact of stress on addiction /Goeders N.E. // Eur. Neuropsychopharmacol. 2003. V. 13. P.435–441.

Gotter, A. L. Orexin receptors as therapeutic drug targets. /A. L. Gotter, A. J. Roecker, R. Hargreaves et al. // Progress in Brain Research. – 2012. – Vol.198, – P.48–56.

Greenwell T.N. Corticotropin-releasing factor-1 receptor antagonists decrease heroin self-administration in long-, but not short-access rats. /Greenwell T.N., Funk C.K., Cottone P., Richardson H.N., Chen S.A., Rice K., Lee M.J., Zorrilla E.P., Koob G.F. // Addict Biol. 2009 in press

Griebel G. 4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor(1) receptor antagonist: II. Characterization in rodent models of stress-related disorders /Griebel G., Simiand J., Steinberg R. et al. // J. Pharmacol. Exp. Ther. 2002. V. 301. P.333–345.

Griebel G. Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154, 526 in anxiety models in rodents, comparison with diazepam and buspirone. /Griebel G., Perrault G., Sanger D.J. // Psychopharmacology (Berl.). 1998. V. 138. P.55–66.

Grivel, J. The wake-promoting hypocretin/orexin neurons change their response to horadrenaline after sleep deprivation. /J. Grivel, V. Cvetkovic, L. Bayer et al. // J.Neurosci. – 2005. – Vol.25, – P.4127–4130.

Gualillo O. Effect of food restriction on ghrelin in normal-cycling female rats and in pregnancy. /Gualillo, O., Caminos, J.E., Nogueiras, R., Seoane, L.M., Arvat, E., Ghigo, E., Casanueva, F.F., Dieguez, C. // Obesity Research 10 (7) – 2002 – Р.682–687.

Guan, X.M. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. /Guan, X.M., Yu, H., Palyha, O.C., McKee, K.K., Feighner, S.D., Sirinathsinghji, D.J.S., Smith, R.G., VanderPloeg, L.H.T., Howard, A.D. // Molecular Brain Research 48 (1) – 1997 – Р.23–29.

Hand G.A. Differential release of corticotropin-releasing hormone (CRH) in the amygdala during different types of stressors /Hand G.A., Hewitt C.B., Fulk L.J. et al. // Brain Res. 2002. V. 949. P.122–130.

Hara, J. C. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. /J. Hara, C. T. Beuckmann, T. Nambu et al. // Neuron. – 2001. – Vol.30, – P.345–354.

Haynes, A. C. A selective orexin-1 receptor antagonist reduces food consumption in male and female rats. /A. C. Haynes, B. Jackson, H. Chapman et al. // Regulatory Peptides. – 2000. – Vol.96, – P.45–51.

Haynes, A. C. Anorectic, thermogenic and anti-obesity activity of a selective orexin-1 receptor antagonist in ob/ob mice. /A. C. Haynes, H. Chapman, C Taylor et al. // Regulatory Peptides. – 2002. – Vol.104, – P.153–159.

Hernandez G. Prolonged rewarding stimulation of the rat medial forebrain bundle: neurochemical and behavioral consequences. /Hernandez G, Hamdani S, Rajabi H, Conover K, Stewart J, Arvanitogiannis A, Shizgal P. // Behav Neurosci 2006;120:888–904.

Heyser C.J., Central administration of an opiate antagonist decreases oral ethanol self-administration in rats. /Heyser C.J., Roberts A.J., Schulteis G., Koob G.F. // Alcohol Clin Exp Res 1999;23:1468–1476.

Holst, B. Constitutive ghrelin receptor activity as a signaling set-point in appetite regulation Trends in Pharmacological. /Holst, B., Schwartz, T.W. // Sciences 25 (3) – 2004 – Р.113–117.

Holst, B. High constitutive signaling of the ghrelin receptor – identification of a potent inverse agonist. /Holst, B., Cygankiewicz, A., Jensen, T.H., Ankersen, M., Schwartz, T.W // Molecular Endocrinology 17 (11) – 2003 – Р.2201–2210.

Howard, A.D. A receptor in pituitary and hypothalamus that functions in growth hormone release. /Howard, A.D., Feighner, S.D., Cully, D.F., Arena, J.P., Liberator, P.A., Rosenblum, C.I., Hamelin, M., Hreniuk, D.L., Palyha, O.C., Anderson, J., Paress, P.S., Diaz, C., Chou, M., Liu, K.K., McKee, K.K., Pong, S.S., Chaung, L.Y., Elbrecht, A., Dashkevicz, M., Heavens, R., Rigby, M., Sirinathsinghji, D.J.S., Dean, D.C., Melillo, D.G., Patchett, A.A., Nargund, R., Griffin, P.R., DeMartino, J.A., Gupta, S.K., Schaeffer, J.M., Smith, R.G., VanderPloeg, L.H.T. // Science 273 (5277) - 1996 – Р.974–977.

Ida T. Possible involvement of orexin in the stress reaction in rats. /Ida T., Nakahara K., Murakami T., Hanada R., Nakazato M., Murakami N. // BiochemBiophys Res Commun. 2000; 270:318–23. []

Ikemoto S. Dissociations between appetitive and consummatory responses by pharmacological manipulations of rewardrelevant brain regions /Ikemoto S., Panksepp J. // Behav. Neurosci. 1996. V.110. №2. P.331–345.

Jerlhag E. Alpha-conotoxin MII-sensitive nicotinic acetylcholine receptors are involved in mediating the ghrelin-induced locomotor stimulation and dopamine overflow in nucleus accumbens. / Jerlhag, E., Egecioglu, E., Dickson, S.L., Svensson, L., Engel, J.A. // European Neuropsychopharmacolology 18 (7) – 2008 – Р.508–518.

Jerlhag E. Ghrelin receptor antagonism attenuates cocaine- and amphetamine-induced locomotor stimulation, accumbal dopamine release, and conditioned place preference. /Jerlhag, E., Egecioglu, E., Dickson, S.L., Engel, J.A. // Psychopharmacology (Berl) 211 (4) – 2010 – Р.415–422.

Jerlhag E. Glutamatergic regulation of ghrelin-induced activation of the mesolimbic dopamine system. /Jerlhag, E., Egecioglu, E., Dickson, S.L., Engel, J.A. // AddictionBiology 16 (1) – 2011 – Р.82–91.